Trial Profile
A Randomized Phase II Prevention Trial in Subjects at High Risk for Hormone Non-responsive Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Nimesulide (Primary) ; Simvastatin (Primary)
- Indications Ductal carcinoma; Early breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Apr 2013 Cardiovascular and inflammatory biomarker analysis presented at the 104th Annual Meeting of the American Association for Cancer Research.
- 31 Dec 2011 New trial record